Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma (MM)

Explore clinical trials studying Multiple Myeloma (MM). Study availability and eligibility vary by location and protocol.

56 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma (MM) trial results

Completed

Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies

NCT00710528

Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Cardiovascular Diseases, +29 more
Locations
  • Stanford Cancer Center Palo Alto, California, United States
  • The Sidney Kimmel Comprehensive Cancer Center at John Hopkins Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Active, Not Recruiting

Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma

NCT04649073

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Tokai University Hospital Isehara-shi, Japan
  • Nagoya City University Hospital Nagoya, Japan
  • National Hospital Organization Okayama Medical Center Okayama, Japan
  • Sapporo Medical University Hospital Sapporo, Japan
View Trial Details

Related conditions